Source | us.nlm.vsac#0.11.0:null (v4.0.1) |
resourceType | ValueSet |
id | 2.16.840.1.113883.3.3616.200.110.102.10000 |
canonical | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.10000 |
version | 20221206 |
status | active |
publisher | Clinical Architecture |
name | SARSCoV2VaccinesAll |
title | SARS CoV 2 Vaccines, All |
date | 2023-06-21T18:16:37-04:00 |
experimental | false |
Usages |
|
This value set contains 33 concepts
Code | System | Display |
207 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose |
208 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose |
210 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL |
211 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose |
212 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL |
213 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED |
217 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation |
218 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation |
219 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation |
221 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose |
227 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose |
228 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose |
229 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose |
300 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation |
301 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation |
500 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown |
501 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN) |
502 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN) |
503 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC) |
504 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light) |
505 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V) |
506 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology |
507 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences) |
508 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention) |
509 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona) |
510 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm) |
511 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac) |
512 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz) |
513 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax) |
514 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D) |
515 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901) |
516 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) |
517 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax) |
Produced 08 Sep 2023